Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: PROSTATIC NEOPLASMS - GENETICS , . Treffer: 17

2018

Renner, W; Krenn-Pilko, S; Gruber, HJ; Herrmann, M; Langsenlehner, T Relative telomere length and prostate cancer mortality.
Prostate Cancer Prostatic Dis. 2018; 21(4):579-583
Web of Science PubMed FullText FullText_MUG

 

2017

Renner, W; Langsenlehner, U; Krenn-Pilko, S; Eder, P; Langsenlehner, T BCL2 genotypes and prostate cancer survival.
Strahlenther Onkol. 2017; 193(6):466-471 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Smolle, MA; Bauernhofer, T; Pummer, K; Calin, GA; Pichler, M Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer.
Int J Mol Sci. 2017; 18(2): [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2016

Belic, J; Koch, M; Ulz, P; Auer, M; Gerhalter, T; Mohan, S; Fischereder, K; Petru, E; Bauernhofer, T; Geigl, JB; Speicher, MR; Heitzer, E mFast-SeqS as a Monitoring and Pre-screening Tool for Tumor-Specific Aneuploidy in Plasma DNA.
Adv Exp Med Biol. 2016; 924:147-155
Web of Science PubMed FullText FullText_MUG

 

Rausch, S; Hennenlotter, J; Scharpf, M; Teepe, K; Kühs, U; Aufderklamm, S; Bier, S; Mischinger, J; Gakis, G; Stenzl, A; Schwentner, C; Todenhöfer, T Prostate tumor overexpressed 1 expression in invasive urothelial carcinoma.
J Cancer Res Clin Oncol. 2016; 142(5):937-947
Web of Science PubMed FullText FullText_MUG

 

Trummer, O; Langsenlehner, U; Krenn-Pilko, S; Pieber, TR; Obermayer-Pietsch, B; Gerger, A; Renner, W; Langsenlehner, T Vitamin D and prostate cancer prognosis: a Mendelian randomization study.
World J Urol. 2016; 34(4):607-611 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Ulz, P; Belic, J; Graf, R; Auer, M; Lafer, I; Fischereder, K; Webersinke, G; Pummer, K; Augustin, H; Pichler, M; Hoefler, G; Bauernhofer, T; Geigl, JB; Heitzer, E; Speicher, MR Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer.
Nat Commun. 2016; 7(15):12008-12008 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2015

Belic, J; Koch, M; Ulz, P; Auer, M; Gerhalter, T; Mohan, S; Fischereder, K; Petru, E; Bauernhofer, T; Geigl, JB; Speicher, MR; Heitzer, E Rapid Identification of Plasma DNA Samples with Increased ctDNA Levels by a Modified FAST-SeqS Approach.
Clin Chem. 2015; 61(6):838-849 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2014

Kaushik, AK; Vareed, SK; Basu, S; Putluri, V; Putluri, N; Panzitt, K; Brennan, CA; Chinnaiyan, AM; Vergara, IA; Erho, N; Weigel, NL; Mitsiades, N; Shojaie, A; Palapattu, G; Michailidis, G; Sreekumar, A Metabolomic profiling identifies biochemical pathways associated with castration-resistant prostate cancer.
J Proteome Res. 2014; 13(2):1088-1100 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Langsenlehner, T; Thurner, EM; Renner, W; Gerger, A; Kapp, KS; Langsenlehner, U Association of genetic variants in VEGF-A with clinical recurrence in prostate cancer patients treated with definitive radiotherapy.
Strahlenther Onkol. 2014; 190(4):364-369
Web of Science PubMed FullText FullText_MUG

 

Thurner, EM; Krenn-Pilko, S; Langsenlehner, U; Renner, W; Gerger, A; Kapp, KS; Langsenlehner, T Association of genetic variants in apoptosis genes FAS and FASL with radiation-induced late toxicity after prostate cancer radiotherapy.
Strahlenther Onkol. 2014; 190(3):304-309
Web of Science PubMed FullText FullText_MUG

 

2011

Langsenlehner, T; Renner, W; Gerger, A; Hofmann, G; Thurner, EM; Kapp, KS; Langsenlehner, U Association between single nucleotide polymorphisms in the gene for XRCC1 and radiation-induced late toxicity in prostate cancer patients.
Radiother Oncol. 2011; 98(3):387-393
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2008

Langsenlehner, T; Kapp, KS; Langsenlehner, U TGFB1 single-nucleotide polymorphisms are associated with adverse quality of life in prostate cancer patients treated with radiotherapy. In regard to Peters et al. (Int J Radiat Oncol Biol Phys 2008;70:752-759).
Int J Radiat Oncol Biol Phys. 2008; 71(3): 960; author reply 960-960; author reply 961.
Web of Science PubMed FullText FullText_MUG

 

Langsenlehner, T; Langsenlehner, U; Renner, W; Kapp, KS; Krippl, P; Hofmann, G; Clar, H; Pummer, K; Mayer, R The Glu228Ala polymorphism in the ligand binding domain of death receptor 4 is associated with increased risk for prostate cancer metastases.
Prostate. 2008; 68(3):264-268
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Langsenlehner, T; Langsenlehner, U; Renner, W; Krippl, P; Mayer, R; Wascher, TC; Kapp, KS Single nucleotide polymorphisms and haplotypes in the gene for vascular endothelial growth factor and risk of prostate cancer.
Eur J Cancer. 2008; 44(11):1572-1576
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2007

Eder, T; Mayer, R; Langsenlehner, U; Renner, W; Krippl, P; Wascher, TC; Pummer, K; Kapp, KS Interleukin-10 [ATA] promoter haplotype and prostate cancer risk: a population-based study.
Eur J Cancer. 2007; 43(3):472-475
Web of Science PubMed FullText FullText_MUG

 

2003

Kraus, J; Pantel, K; Pinkel, D; Albertson, DG; Speicher, MR High-resolution genomic profiling of occult micrometastatic tumor cells.
Genes Chromosomes Cancer. 2003; 36(2):159-166
Web of Science PubMed FullText FullText_MUG

 

© Med Uni Graz Impressum